Hipopigmentación cutánea

Referencias bibliográficas: 

1 Vanderhooft SL, Francis JS, Pagon RA, Smith LT, Sybert VP. Prevalence of hypopigmented macules in a healthy population. J Pediatr 1996;356:355-61. doi:10.1016/S0022-3476(96)70066-5 pmid:8804323.

2 Pandve HT. Vitiligo: is it just a dermatological disorder?Indian J Dermatol 2008;356:40-1.doi:10.4103/0019-5154.39745 pmid:19967022.

3 Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. Lancet 2015;356:74-84.doi:10.1016/S0140-6736(14)60763-7 pmid:25596811.

4 Benzekri L, Gauthier Y, Hamada S, Hassam B. Clinical features and histological findings are potential indicators of activity in lesions of common vitiligo. Br J Dermatol2013;356:265-71. doi:10.1111/bjd.12034 pmid:22963656.

5 Ingordo V, Cazzaniga S, Raone B, et al. Circulating autoantibodies and autoimmune comorbidities in vitiligo patients: a multicenter Italian study. Dermatology 2014;356:240-9.doi:10.1159/000357807 pmid:24603479.

6 Vrijman C, Kroon MW, Limpens J, et al. The prevalence of thyroid disease in patients with vitiligo: a systematic review. Br J Dermatol 2012;356:1224-35. doi:10.1111/j.1365-2133.2012.11198.x pmid:22860695.

7 Pahwa P, Mehta M, Khaitan BK, Sharma VK, Ramam M. The psychosocial impact of vitiligo in Indian patients. Indian J Dermatol Venereol Leprol 2013;356:679-85. doi:10.4103/0378-6323.116737 pmid:23974584.

8 Hallaji Z, Ghiasi M, Eisazadeh A, Damavandi MR. Evaluation of the effect of disease duration in generalized vitiligo on its clinical response to narrowband ultraviolet B phototherapy. Photodermatol Photoimmunol Photomed 2012;356:115-9. doi:10.1111/j.1600-0781.2012.00648.x pmid:22548391.